Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy.

Acta Pharm Sin B · 2024 · PMC11143529 · PMID 38828136

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

3.3 Reducing affinity of CD3 arm Studies have highlighted a significant trend in T-cell redirecting BsAbs associating affinity for CD3 with pharmacokinetic properties 124 , 125 .

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.